A recent study reported an increased proportion of CD3+, CD8+, and HLA-DR on CD8+ T-cells, and a lower percentage of CD19+ B-cells, among ME/CFS patients compared to healthy controls, but with no associations to ME/CFS severity or disease duration [46]. Here, CD19 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.